ArticlePlant biotechnology journal2026
Gene Editing of Nicotiana benthamiana Architecture for Space-Efficient Production of Recombinant Proteins in Closed Environments.
Article in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and Optimization of a Non-Tissue Culture Hairy Root Transformation System inPlants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Indoor vertical farming (VF) offers practical advantages for the cultivation of plant protein bio-factories including plant uniformity, product consistency, water/nutrient recycling and production cycles on a year-round basis. Much progress has been achieved toward the development of innovative systems for artificial lighting, automated irrigation, plant handling, environmental control and space use optimization in VF systems. Here, we used a CRISPR/Cas9 gene editing approach to generate mutant lines of protein expression host Nicotiana benthamiana presenting a compact, space-efficient phenotype suited to VF systems. Our strategy consisted of altering apical dominance by suppressing the synthesis of strigolactone, a negative regulator of axillary bud outgrowth. Strigolactone-depleted lines were generated by hindering the expression of either Carotenoid cleavage dioxygenase 7 (CCD7) or Carotenoid cleavage dioxygenase 8 (CCD8), two key enzymes of the strigolactone synthetic pathway. Knocking out of either enzyme had no impact on the plant's growth rate but drastically influenced its auxin/cytokinin ratio, leaf proteome and overall architecture. The ΔCCD mutants exhibited an axillary growth-oriented development pattern, altered glycolytic and malate-processing metabolic fluxes to drive pyruvate and cytokinin production, and a spatial footprint reduced by 45%-50% compared to the LAB strain commonly used for protein expression. Most importantly, recombinant protein yields per plant were maintained in the mutant lines, as illustrated with GFP and rituximab, a chimeric antibody of therapeutic value. Our data confirm the usefulness of ΔCCD7 and ΔCCD8 knockouts leading to strigolactone depletion for the generation of compact, space-efficient N. benthamiana lines better suited to VF systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.